These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 26004537

  • 1. cAMP signalling in trypanosomatids: role in pathogenesis and as a drug target.
    Makin L, Gluenz E.
    Trends Parasitol; 2015 Aug; 31(8):373-9. PubMed ID: 26004537
    [Abstract] [Full Text] [Related]

  • 2. cAMP signalling in the kinetoplastid protozoa.
    Seebeck T, Schaub R, Johner A.
    Curr Mol Med; 2004 Sep; 4(6):585-99. PubMed ID: 15357210
    [Abstract] [Full Text] [Related]

  • 3. Phosphodiesterase regulation of alcohol drinking in rodents.
    Logrip ML.
    Alcohol; 2015 Dec; 49(8):795-802. PubMed ID: 26095589
    [Abstract] [Full Text] [Related]

  • 4. cAMP signalling in Trypanosoma brucei.
    Seebeck T, Gong K, Kunz S, Schaub R, Shalaby T, Zoraghi R.
    Int J Parasitol; 2001 May 01; 31(5-6):491-8. PubMed ID: 11334934
    [Abstract] [Full Text] [Related]

  • 5. The adenylate cyclase UvAc1 and phosphodiesterase UvPdeH control the intracellular cAMP level, development, and pathogenicity of the rice false smut fungus Ustilaginoidea virens.
    Guo W, Gao Y, Yu Z, Xiao Y, Zhang Z, Zhang H.
    Fungal Genet Biol; 2019 Aug 01; 129():65-73. PubMed ID: 31063805
    [Abstract] [Full Text] [Related]

  • 6. Signal Transduction Pathways as Therapeutic Target for Chagas Disease.
    Schoijet AC, Sternlieb T, Alonso GD.
    Curr Med Chem; 2019 Aug 01; 26(36):6572-6589. PubMed ID: 31218950
    [Abstract] [Full Text] [Related]

  • 7. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J, Grande JP.
    Exp Biol Med (Maywood); 2007 Jan 01; 232(1):38-51. PubMed ID: 17202584
    [Abstract] [Full Text] [Related]

  • 8. Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism.
    McGwire BS, Kulkarni MM.
    Exp Parasitol; 2010 Nov 01; 126(3):397-405. PubMed ID: 20159013
    [Abstract] [Full Text] [Related]

  • 9. Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei.
    Rascón A, Soderling SH, Schaefer JB, Beavo JA.
    Proc Natl Acad Sci U S A; 2002 Apr 02; 99(7):4714-9. PubMed ID: 11930017
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological modulation of the CO2/HCO3-/pH-, calcium-, and ATP-sensing soluble adenylyl cyclase.
    Wiggins SV, Steegborn C, Levin LR, Buck J.
    Pharmacol Ther; 2018 Oct 02; 190():173-186. PubMed ID: 29807057
    [Abstract] [Full Text] [Related]

  • 11. The TryPIKinome of five human pathogenic trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, Leishmania braziliensis and Leishmania infantum--new tools for designing specific inhibitors.
    Bahia D, Oliveira LM, Lima FM, Oliveira P, Silveira JF, Mortara RA, Ruiz JC.
    Biochem Biophys Res Commun; 2009 Dec 18; 390(3):963-70. PubMed ID: 19852933
    [Abstract] [Full Text] [Related]

  • 12. Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves".
    Getz M, Rangamani P, Ghosh P.
    Wiley Interdiscip Rev Syst Biol Med; 2020 Sep 18; 12(5):e1490. PubMed ID: 32323924
    [Abstract] [Full Text] [Related]

  • 13. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
    Gupta R, Kumar G, Kumar RS.
    Methods Find Exp Clin Pharmacol; 2005 Mar 18; 27(2):101-18. PubMed ID: 15834463
    [Abstract] [Full Text] [Related]

  • 14. The trypanothione system and its implications in the therapy of trypanosomatid diseases.
    Flohé L.
    Int J Med Microbiol; 2012 Oct 18; 302(4-5):216-20. PubMed ID: 22889611
    [Abstract] [Full Text] [Related]

  • 15. Cyclic AMP second messenger systems.
    McKnight GS.
    Curr Opin Cell Biol; 1991 Apr 18; 3(2):213-7. PubMed ID: 1652989
    [Abstract] [Full Text] [Related]

  • 16. cAMP signaling in Dictyostelium. Complexity of cAMP synthesis, degradation and detection.
    Saran S, Meima ME, Alvarez-Curto E, Weening KE, Rozen DE, Schaap P.
    J Muscle Res Cell Motil; 2002 Apr 18; 23(7-8):793-802. PubMed ID: 12952077
    [Abstract] [Full Text] [Related]

  • 17. Elucidating cyclic AMP signaling in subcellular domains with optogenetic tools and fluorescent biosensors.
    Klausen C, Kaiser F, Stüven B, Hansen JN, Wachten D.
    Biochem Soc Trans; 2019 Dec 20; 47(6):1733-1747. PubMed ID: 31724693
    [Abstract] [Full Text] [Related]

  • 18. Cyclic AMP effectors in African trypanosomes revealed by genome-scale RNA interference library screening for resistance to the phosphodiesterase inhibitor CpdA.
    Gould MK, Bachmaier S, Ali JA, Alsford S, Tagoe DN, Munday JC, Schnaufer AC, Horn D, Boshart M, de Koning HP.
    Antimicrob Agents Chemother; 2013 Oct 20; 57(10):4882-93. PubMed ID: 23877697
    [Abstract] [Full Text] [Related]

  • 19. Large-Scale Phylogenetic Analysis of Trypanosomatid Adenylate Cyclases Reveals Associations with Extracellular Lifestyle and Host-Pathogen Interplay.
    Durante IM, Butenko A, Rašková V, Charyyeva A, Svobodová M, Yurchenko V, Hashimi H, Lukeš J.
    Genome Biol Evol; 2020 Dec 06; 12(12):2403-2416. PubMed ID: 33104188
    [Abstract] [Full Text] [Related]

  • 20. Compartmentalization of cyclic AMP phosphodiesterases, signalling 'crosstalk', desensitization and the phosphorylation of Gi-2 add cell specific personalization to the control of the levels of the second messenger cyclic AMP.
    Houslay MD.
    Adv Enzyme Regul; 1995 Dec 06; 35():303-38. PubMed ID: 7572351
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.